The U.S. Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Fisher Scientific Company L.L.C.'s Fisher Healthcare division. This single-award contract, which falls under the General Services Administration's (GSA) Federal Supply Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test Kits, has a ceiling value of $460,313.68 and a period of performance ending on September 30, 2025.
Under this BPA, Fisher Healthcare will provide microbiology media and supplies to support diagnostic capabilities and infection management at VA medical facilities. Two specific task orders have been issued so far, valued at $88,084.11 and $460,313.68, both with firm fixed pricing. Fisher Scientific Company has a history of delivering a range of medical equipment, testing reagents, laboratory supplies, and inventory services to federal agencies, including the CDC's BioWatch program and COVID-19 surveillance efforts. This contract vehicle allows the VA to efficiently procure necessary materials while maintaining flexibility to address evolving diagnostic requirements at its facilities.
Generated 11/15/24, 9:04 AM